Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission

Gerald P. Bodey, Victorio Rodriguez, Fernando Cabanillas, Emil J. Freireich

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Fifty-eight patients with malignant lymphoma were randomly allocated to receive three courses of chemotherapy to induce remission with CHOP-Bleo on the protected environment-prophylactic antibiotic (PEPA) program (30 patients) or as controls (28 patients). The complete remission rate for all patients was 74 per cent, for patients with diffuse histiocytic lymphoma 78 per cent and for patients with nodular poorly differentiated lymphocytic lymphoma 65 per cent. There were no significant differences in response rates and duration of responses between those on the PEPA program and control patients. The frequency of infection was significantly lower among the patients on the PEPA program, and dosage escalation of the chemotherapeutic agents was accomplished more often among these patients. Dosage escalation did not increase the complete remission rate, but it did reduce the relapse rate and significantly reduced the fatality rate. The duration of remission and survival was significantly longer for those patients who received dosage escalation.

Original languageEnglish (US)
Pages (from-to)74-81
Number of pages8
JournalThe American journal of medicine
Volume66
Issue number1
DOIs
StatePublished - Jan 1979

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission'. Together they form a unique fingerprint.

Cite this